Literature DB >> 6701091

Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes.

G J Grindlay, W G Lanyon, M Allan, J Paul.   

Abstract

Using S1 mapping and primer extension analysis, we have identified a number of human kappa-globin and beta-globin 5' RNA termini originating in the 200 bp upstream of the canonical mRNA cap sites. Upstream initiation sites have previously been reported for the human epsilon-globin gene (4,5) and the present work indicates that this is a general feature of the human beta-type globin genes. We have attempted to identify features common to such sites between the three genes. One site 170 bp upstream of the major beta-globin cap site and a site 1400 bp upstream of the major epsilon-globin cap site are located near putative PolIII promoter sequences and may therefore be transcribed by this enzyme. Alternative initiation sites located 200 bp and 50-100 bp upstream of the epsilon-globin and kappa-globin cap sites respectively are located within S1 hypersensitive regions of chromatin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6701091      PMCID: PMC318622          DOI: 10.1093/nar/12.4.1811

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates.

Authors:  R F Weaver; C Weissmann
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

2.  Determination of RNA sequences by primer directed synthesis and sequencing of their cDNA transcripts.

Authors:  P K Ghosh; V B Reddy; M Piatak; P Lebowitz; S M Weissman
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  Sequences at the capped 5'-ends of polyoma virus late region mRNAs: an example of extreme terminal heterogeneity.

Authors:  A Cowie; C Tyndall; R Kamen
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

4.  Fine structure of the origin-proximal DNAase I-hypersensitive region in wild-type and EC mutant polyoma.

Authors:  P Herbomel; S Saragosti; D Blangy; M Yaniv
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

5.  Characterization of the 5'-terminal cap structures of early simian virus 40 mRNA.

Authors:  G Haegeman; W Fiers
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

6.  Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells.

Authors:  P Dierks; A van Ooyen; M D Cochran; C Dobkin; J Reiser; C Weissmann
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

Review 7.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  The G gamma:A gamma composition of fetal hemoglobin in fetuses and newborns.

Authors:  B P Alter
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

10.  Epsilon globin gene transcripts originating upstream of the mRNA cap site in K562 cells and normal human embryos.

Authors:  M Alan; G J Grindlay; L Stefani; J Paul
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

View more
  21 in total

1.  Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Authors:  Hideki Hanawa; Derek A Persons; Arthur W Nienhuis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Characterization of an unique RNA initiated immediately upstream from human alpha 1 globin gene in vivo and in vitro: polymerase II-dependence, tissue specificity, and subcellular location.

Authors:  J Hess; C Perez-Stable; A Deisseroth; C K Shen
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

3.  Point mutation associated with hereditary persistence of fetal hemoglobin decreases RNA polymerase III transcription upstream of the affected gamma-globin gene.

Authors:  D P Carlson; J Ross
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

4.  Negative regulation of the human epsilon-globin gene by transcriptional interference: role of an Alu repetitive element.

Authors:  J Wu; G J Grindlay; P Bushel; L Mendelsohn; M Allan
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  Correlation between patterns of DNase I-hypersensitive sites and upstream promoter activity of the human epsilon-globin gene at different stages of erythroid development.

Authors:  P Bushel; K Rego; L Mendelsohn; M Allan
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  RNA processing of beta-globin transcripts containing 5' flanking and structural gene sequences.

Authors:  I Winicov
Journal:  Nucleic Acids Res       Date:  1988-01-25       Impact factor: 16.971

7.  Alpha-amanitin insensitive transcription of the human epsilon-globin gene.

Authors:  G Kollias; C E Sekeris; F G Grosveld
Journal:  Nucleic Acids Res       Date:  1985-11-25       Impact factor: 16.971

8.  Structural and transcriptional analysis of DNA sequences flanking genes that encode 19 kilodalton zeins.

Authors:  A L Kriz; R S Boston; B A Larkins
Journal:  Mol Gen Genet       Date:  1987-04

9.  Changes in minor transcripts from the alpha 1 and beta maj globin and glutathione peroxidase genes during erythropoiesis.

Authors:  J Frampton; D Conkie; I Chambers; W McBain; M Dexter; P Harrison
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

10.  Gene expression of the chondroitin sulfate proteoglycan core protein PG19.

Authors:  M A Bourdon; M Shiga; E Ruoslahti
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.